Drug Repositioning Summary

Networked: 57 relevant articles (5 outcomes, 5 trials/studies) for this Therapy

Key Diseases for which Drug Repositioning is Relevant

1. Neoplasms (Cancer) : 1 outcome 2 studies in 15 results
   
2. Rare Diseases (Rare Disease) : 1 outcome 1 study in 2 results
   
3. Tuberculosis (Tuberculoses) : 1 outcome in 1 result
   
4. Heterotopic Ossification (Ectopic Ossification) : 1 outcome in 1 result
   
5. Colonic Neoplasms (Colon Cancer) : 1 outcome in 1 result
   

Drugs Related to Drug Repositioning

1. Staphylococcal Protein A (A, Protein)
2. Mebendazole (Vermin)
3. butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)
4. perhexiline maleate
5. Amyloid Precursor Protein Secretases (beta-Secretase)
6. Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
7. nitazoxanide (NTZ)
8. Type 5 Cyclic Nucleotide Phosphodiesterases
9. Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
10. Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)

Therapies Related to Drug Repositioning

1. Therapeutics
2. Individualized Medicine
3. Complementary Therapies (Alternative Medicine)